Showing results (131-140 of 8,954) with videos related to
Sort By:
Pageof 896
Journal of Hepatology|March 22, 2021
A notable proportion of liver transplant candidates with alcohol-related cirrhosis can be delisted because of clinical improvementElisa Pose, Abiguei Torrents, Enric Reverter, et al.Journal of Hepatology|March 25, 2021
Clinical efficacy of a novel, high-sensitivity HBcrAg assay in the management of chronic hepatitis B and HBV reactivationTakako Inoue, Shigeru Kusumoto, Etsuko Iio, et al.Journal of Hepatology|February 1, 1987
Reversal of adrenaline-induced increase in azygos blood flow in patients with cirrhosis receiving propranololD Valla, C Gaudin, P Geoffroy, et al.Journal of Hepatology|February 1, 1987
Reliability of endoscopy in the assessment of variceal features. The Italian Liver Cirrhosis ProjectJournal of Hepatology|January 1, 1986
Immunopathological mechanisms of liver cell injury in chronic hepatitis B virus infectionA L Eddleston, M MondelliJournal of Hepatology|June 1, 1987
Prolonged cholestasis after troleandomycin-induced acute hepatitisD Larrey, G Amouyal, G Danan, et al.Journal of Hepatology|July 30, 2011
New horizons for stem cell therapy in liver diseaseStuart J Forbes, Philip N NewsomeJournal of Hepatology|February 9, 2012
Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinomaFlorie Borel, Pavlina Konstantinova, Peter L M JansenJournal of Hepatology|February 9, 2012
A phase 1, randomized, placebo-controlled, 3-day, dose-ranging study of GS-5885, an NS5A inhibitor, in patients with genotype 1 hepatitis CEric J Lawitz, Daniel Gruener, John M Hill, et al.Journal of Hepatology|February 9, 2012
Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial designMarta Burrel, María Reig, Alejandro Forner, et al.Pageof 896